CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Matthew Rabinowitz

Executive Chairman and Co-Founder, Natera, Inc.

Search every verified Matthew Rabinowitz interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Matthew Rabinowitz, co-founder and executive chairman of Natera, has discussed the company's work in genetic testing and its origins in a personal family tragedy. In a November 2024 podcast appearance, he recounted that his sister's child with Down syndrome died six days after birth, which motivated him to apply his background in electrical engineering to develop prenatal screening technology. He described using a sample from that pregnancy to submit data to the NIH and subsequently receiving funding to improve prenatal testing, leading to the development of the Panorama test. Rabinowitz also noted that some investors were skeptical of Natera's ability to build a profitable maternal health business while simultaneously developing an oncology business. In earlier appearances, Rabinowitz explained Natera's approach to cell-free DNA testing, which applies statistical techniques from communication systems to analyze DNA in plasma for detecting genetic diseases such as Down syndrome and breast cancer. He discussed the company's strategy of making substantial investments in low-risk prenatal testing and cancer research, as well as its cloud-based model that enables labs worldwide to run tests. Rabinowitz also addressed ethical considerations in genetic testing, stating that the company focuses on serious disease conditions and employs genetic counselors to discuss abnormal results with doctors and patients. He observed that patient decisions regarding pregnancy termination for conditions like Down syndrome vary significantly by region, with over 80 percent of people in some states choosing termination and over 80 percent in others choosing not to.

Recent appearances

  • How To Save $200 BILLION Annually in Healthcare Costs through Preventive Genomic Medicine with MyOme

    February 21, 2025 · 📺 DNA Today

    How can preventive genomic medicine save $200 billion annually in healthcare costs? Dr. Matthew Rabinowitz breaks it down in this episode. Dr. Rabinowitz—a true pioneer in genetics, diagnostics, and AI—who’s been at the forefront of transforming how we approach health and medicine. Dr. Rabinowitz isn’t just a scientist; he’s a visionary who’s helped create groundbreaking technologies, from revolutionizing pregnancy care to tracking cancer through blood tests. In 2024, he was named R&D Leader of the Year by R&D World. Now, he’s tackling preventative genomic medicine, showing us how tools like…

    Watch on YouTube ↗

  • Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution

    November 21, 2024 · 📺 Sequoia Capital

    Founder Matthew Rabinowitz opens up about the intensely personal journey that set him on a course to revolutionizing healthcare. A PhD in electrical engineering, he had no background in genetics or biology, but after his sister had a baby with Down syndrome that hadn’t been detected and tragically died after 6 days, Matthew dedicated himself to solving this problem. After overcoming seemingly impossible obstacles, today Natera leverages molecular biology and novel bioinformatics technology to provide prenatal screening in nearly half of U.S. pregnancies, as well as transforming oncology and or…

    Watch on YouTube ↗

  • Natera: Managing Disease Via Genetic Sequencing

    July 02, 2015 · 📺 Bloomberg Originals

    July 2 -- Matthew Rabinowitz, chief executive officer at Natera, explains the process of detecting diseases via genetic testing and the investment of money from his company’s initial public offering. He speaks on “Bloomberg Markets.”

    Watch on YouTube ↗

  • Stanford Seminar - Entrepreneurial Though Leaders: Matt Rabinowitz of Natera

    October 25, 2013 · 📺 Stanford Online

    Matt Rabinowitz Natera In this seminar, entrepreneurial leaders share lessons from real-world experiences across entrepreneurial settings. Speakers include entrepreneurs, leaders from global technology companies, venture capitalists, and best-selling authors. Half-hour talks are followed by a half hour of class interaction. Learn more about Stanford's eCorner: https://ecorner.stanford.edu Learn more about Stanford's online classes and certificates: https://online.stanford.edu/programs See the full playlist:    • MS&E472 - Entrepreneurial Thought Leaders ...  

    Watch on YouTube ↗

  • Matthew Rabinowitz: Monkeys and Managing Your Emotions

    October 10, 2013 · 📺 Stanford eCorner

    Serial entrepreneur Matthew Rabinowitz unpacks why it's important for entrepreneurs to manage their emotions, with the telling of an early career experience and its amusing comparison to how monkeys are trapped in West Africa. View more clips and share your comments at http://ecorner.stanford.edu/authorMat...

    Watch on YouTube ↗

  • Technology Pioneer 2014⎪Matthew Rabinowitz⎪Natera

    August 27, 2013 · 📺 World Economic Forum

    http://www.weforum.org/ Technology Pioneer 2014, Matthew Rabinowitz, CEO of Natera.

    Watch on YouTube ↗

  • CLB Symposium | Corporate Perspectives

    June 19, 2012 · 📺 Stanford Law School

    On May 29th, 2012 Stanford's Center for Law and the Biosciences along with the Stanford Center for Integration of Research in Genetics and Ethics hosted "Informing Reproductive Choice? Prenatal Genetic Testing in the 21st Century." The conference hosted a broad range of experts who analyzed recent developments in the industry, their practical, legal and social implications, and future directions of the prenatal testing revolution. In this video Ariosa's Kenneth Song, Natera's Matthew Rabinowitz and CellScrape's Bhairavi Parikh discuss Corporate Perspective.

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →